IO Biotech is a Biotech company based in Copenhagen, Denmark. It has raised $250M in total funding. Latest round: IPO.
IO Biotech funding overview
IO Biotech is a Biotech company based in Copenhagen, Denmark. IO Biotech has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in November 2021. The round record for IO Biotech runs through 2021; nothing later has been disclosed. Investors on record include Novo Seeds, Merck (MSD), Forbion, Sofinnova Partners, Monograph Capital, Weatherden. 6 distinct backers are named across the disclosed rounds.
IO Biotech at a glance
Total raised
$250M
Latest round
IPO
Latest round date
November 2021
Industry
Biotech
Headquarters
Copenhagen, Denmark
Notable investors
Novo Seeds, Merck (MSD), Forbion, Sofinnova Partners, Monograph Capital, Weatherden
Frequently asked about IO Biotech funding
How much has IO Biotech raised?
IO Biotech has raised $250M in total disclosed funding across the rounds on record.
Who has invested in IO Biotech?
Novo Seeds, Merck (MSD), Forbion, Sofinnova Partners, Monograph Capital, Weatherden are named among the investors backing IO Biotech.
What was the latest IO Biotech funding round?
The most recent disclosed round is an IPO, announced in November 2021.
Where is IO Biotech based?
IO Biotech is based in Copenhagen, Denmark.
What sector does IO Biotech operate in?
IO Biotech is tracked under Biotech from Copenhagen, Denmark, with $250M in disclosed funding.
When did IO Biotech last raise?
The last disclosed IO Biotech round closed in November 2021 at IPO.
Totals shown for IO Biotech aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Copenhagen and the investors behind them below.
